Although it is too early to define them punctually as inflammatory salivary biomarkers in the DC process, based on the available scientific evidence, it is presumed that, mainly IL-6 and TNF-α levels could be the potential to be considered as complementary tools to clinical and radiographic diagnosis to assess the severity of DC. This evidence concerns the gene IL6 and dyskeratosis congenita.